Brothers, the word is law! After 474 days, Injective’s ETF has finally been approved. As a holder who’s been along for the ride, it’s been no easy journey. The approved ETF is the “Canary Staked INJ ETF,” issued by Canary Capital, with the ticker symbol INJC. In simple terms ⬇️ - Investors can now invest in INJ through their brokerage accounts, just like buying U.S. stocks—no need to buy crypto directly. - This is a staked ETF that tracks the price of INJ while also generating yield through staking. - Note: Approval for listing on Nasdaq has been granted, but trading has not yet begun. Regarding fees: The ETF has an annual management fee of 1.10%. Of the INJ yield generated from staking, 70% remains within the fund, while 30% covers staking-related expenses. Injective (@injective) $INJ The light boat has already sailed past ten thousand mountains ⛵️